首站-论文投稿智能助手
典型文献
Alpha-synuclein as a biomarker in Parkinson's disease: focus on neural derived extracelluar vesicles
文献摘要:
The prevalence of Parkinson's disease (PD) is rapidly increasing, and more than 12 million people are expected to suffer from PD by 2040. PD is a highly invalidating neurodegenerative condition that arises from the progressive degeneration of dopaminergic neurons in the substantia nigra pars compacta. The main cause for such degeneration is the formation of cytoplasmic inclusions known as Lewy bodies, which include both misfolded α-synuclein (α-syn) protein and a multitude of fragmented membranes, organelles, and vesicles (Shahmoradian et al., 2019; Lashuel, 2020). No reliable biomarkers that can predict the onset of PD in its prodromal phase or could assess disease progression are currently available. α-Syn plays a pivotal role in the pathogenesis of PD and is present in peripheral tissues and biofluids; this led to the investigation of α-syn as a possible PD biomarker.
文献关键词:
作者姓名:
Cristina Agliardi;Franca R.Guerini;Mario Meloni;Mario Clerici
作者机构:
IRCCS Fondazione Don Carlo Gnocchi,Milan,Italy;Department of Pathophysiology and Transplantation,University of Milan,Milan,Italy
引用格式:
[1]Cristina Agliardi;Franca R.Guerini;Mario Meloni;Mario Clerici-.Alpha-synuclein as a biomarker in Parkinson's disease: focus on neural derived extracelluar vesicles)[J].中国神经再生研究(英文版),2022(07):1503-1504
A类:
extracelluar,invalidating,Shahmoradian,Lashuel,prodromal
B类:
Alpha,synuclein,Parkinson,disease,focus,neural,derived,vesicles,prevalence,rapidly,increasing,more,than,million,people,are,expected,suffer,from,by,highly,neurodegenerative,condition,that,arises,progressive,degeneration,dopaminergic,neurons,substantia,nigra,pars,compacta,main,cause,such,formation,cytoplasmic,inclusions,known,Lewy,bodies,which,include,both,misfolded,protein,multitude,fragmented,membranes,organelles,No,reliable,biomarkers,can,predict,onset,its,phase,could,assess,progression,currently,available,Syn,plays,pivotal,role,pathogenesis,present,peripheral,tissues,biofluids,this,led,investigation,possible
AB值:
0.636865
相似文献
CHCHD2 maintains mitochondrial contact site and cristae organizing system stability and protects against mitochondrial dysfunction in an experimental model of Parkinson’s disease
Lu Lin;Mao Hengxu;Zhou Miaomiao;Lin Yuwan;Dai Wei;Qiu Jiewen;Xiao Yousheng;Mo Mingshu;Zhu Xiaoqin;Wu Zhuohua;Pei Zhong;Guo Wenyuan;Xu Pingyi;Chen Xiang-Department of Neurology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong 510120, China;Department of Neurology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi 530021, China;School of Basic Medical Sciences, Guangzhou Medical University, Guangzhou, Guangdong 511436, China;Department of Neurology, National Key Clinical Department and Key Discipline of Neurology, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong 510080, China
Deubiquitinase ubiquitin-specific protease 3 (USP3) inhibits HIV-1 replication via promoting APOBEC3G (A3G) expression in both enzyme activity-dependent and -independent manners
Zhao Simin;Zheng Baisong;Wang Liuli;Cui Wenzhe;Jiang Chunlai;Li Zhuo;Gao Wenying;Zhang Wenyan-Center for Pathogen Biology and Infectious Diseases, Institute of Virology and AIDS Research, Key Laboratory of Organ Regeneration and Transplantation of The Ministry of Education, The First Hospital of Jilin University, Changchun, Jilin 130021, China;College of Life Science of Jilin University, Changchun, Jilin 130012, China;Department of Regenerative Medicine, School of Pharmaceutical Sciences, Jilin University, Changchun, Jilin 130012, China;Jilin Provincial Key Laboratory on Molecular and Chemical Genetics, The Second Hospital of Jilin University, Changchun, Jilin 130041, China;Department of Endocrinology and Metabolism, The First Hospital of Jilin University, Changchun, Jilin 130021, China
Alzheimer's disease:current status and perspective
Wenying Liu;Serge Gauthier;Jianping Jia-Innovation Center for Neurological Disorders and Department of Neurology,Xuanwu Hospital,Capital Medical University,National Clinical Research Center for Geriatric Diseases,Beijing 100053,China;Departments of Neurology and Neurosurgery,and Department of Psychiatry,McGill Centre for Studies in Aging,McGill University,Montreal H4H1R3,Canada;Beijing Key Laboratory of Geriatric Cognitive Disorders,Beijing 100053,China;Clinical Center for Neurodegenerative Disease and Memory Impairment,Capital Medical University,Beijing 100053,China;Center of Alzheimer's Disease,Beijing Institute of Brain Disorders,Collaborative Innovation Center for Brain Disorders,Capital Medical University,Beijing 100053,China;Key Laboratory of Neurodegenerative Diseases,Ministry of Education,Beijing 100053,China
Screening of autoantibodies as biomarkers in the serum of renal cancer patients based on human proteome microarray
Yangyang Sun;Chengxi Liu;Huidong Zhong;Chenguang Wang;Haibo Xu;Wei Chen-Shenzhen Key Laboratory of Synthetic Genomics,Guangdong Provincial Key Laboratory of Synthetic Genomics,CAS Key Laboratory of Quantitative Engineering Biology,Shenzhen Institute of Synthetic Biology,Shenzhen Institutes of Advanced Technology,Chinese Academy of Sciences,Shenzhen 518055,China;Department of Urology,Shenzhen Second People's Hospital,the First Affiliated Hospital of Shenzhen University,International Cancer Center,Shenzhen University School of Medicine,Shenzhen 518039,China;State Key Laboratory of Chemical Biology and Drug Discovery,Food Safety and Technology Research Centre and Department of Applied Biology and Chemical Technology,The Hong Kong Polytechnic University,Hong Kong 999077,China;Department of Medicinal Chemistry,Shantou University Medical College,Shantou 515041,China
Structural insights into thyrotropin-releasing hormone receptor activation by an endogenous peptide agonist or its orally administered analogue
Fan Yang;Huanhuan Zhang;Xianyu Meng;Yingge Li;Yingxin Zhou;Shenglong Ling;Demeng Sun;Pei Lv;Lei Liu;Pan Shi;Changlin Tian-The First Affiliated Hospital of USTC,School of Life Sciences,Division of Life Sciences and Medicine,Joint Center for Biological Analytical Chemistry,Anhui Engineering Laboratory of Peptide Drug,Anhui Laboratory of Advanced Photonic Science and Technology,University of Science and Technology of China,Hefei,Anhui,China;Tsinghua-Peking Joint Center for Life Sciences,Ministry of Education Key Laboratory of Bioorganic Phosphorus Chemistry and Chemical Biology,Department of Chemistry,Tsinghua University,Beijing,China;High Magnetic Field Laboratory,Chinese Academy of Sciences,Hefei,Anhui,China
Corynoxine B derivative CB6 prevents Parkinsonian toxicity in mice by inducing PIK3C3 complex-dependent autophagy
Zhou Zhu;Liang-feng Liu;Cheng-fu Su;Jia Liu;Benjamin Chun-Kit Tong;Ashok lyaswamy;Senthilkumar Krishnamoorthi;Sravan Gopalkrishnashetty Sreenivasmurthy;Xin-jie Guan;Yu-xuan Kan;Wen-jian Xie;Chen-liang Zhao;King-ho Cheung;Jia-hong Lu;Jie-qiong Tan;Hong-jie Zhang;Ju-xian Song;Min Li-Mr.&Mrs.Ko Chi-Ming Centre for Parkinson's Disease Research,School of Chinese Medicine,Hong Kong Baptist University,Hong Kong,SAR,China;School of Chinese Medicine,Hong Kong Baptist University,Hong Kong,SAR,China;institute for Research and Continuing Education,Hong Kong Baptist University,Shenzhen 518057,China;Limin Pharmaceutical Factory,Livzon Group Limited,Shaoguan 512028,China;State Key Laboratory of Quality Research in Chinese Medicine,Institute of Chinese Medical Sciences,University of Macau,Macau,SAR,China;Center for Medical Genetics and Hunan Key Laboratory of Animal Model for Human Diseases,School of Life Sciences,Central South University,Changsha 410078,China;Medical College of Acupuncture-Moxibustion and Rehabilitation,Guangzhou University of Chinese Medicine,Guangzhou 510006,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。